image
Healthcare - Medical - Devices - NYSE - US
$ 72.24
1.47 %
$ 2.23 B
Market Cap
17.12
P/E
1. INTRINSIC VALUE

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads.[ Read More ]

The intrinsic value of one CNMD stock under the base case scenario is HIDDEN Compared to the current market price of 72.2 USD, CONMED Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart CNMD

image
FINANCIALS
1.24 B REVENUE
18.70%
131 M OPERATING INCOME
86.69%
64.5 M NET INCOME
179.99%
125 M OPERATING CASH FLOW
275.69%
-20 M INVESTING CASH FLOW
91.97%
-110 M FINANCING CASH FLOW
-49.08%
317 M REVENUE
-4.25%
65.7 M OPERATING INCOME
76.57%
49 M NET INCOME
63.41%
51.2 M OPERATING CASH FLOW
18.24%
-3.42 M INVESTING CASH FLOW
4.76%
-38.8 M FINANCING CASH FLOW
11.92%
Balance Sheet Decomposition CONMED Corporation
image
Current Assets 616 M
Cash & Short-Term Investments 24.3 M
Receivables 242 M
Other Current Assets 349 M
Non-Current Assets 1.68 B
Long-Term Investments -16.6 M
PP&E 137 M
Other Non-Current Assets 1.56 B
Current Liabilities 311 M
Accounts Payable 88.2 M
Short-Term Debt 0
Other Current Liabilities 223 M
Non-Current Liabilities 1.16 B
Long-Term Debt 983 M
Other Non-Current Liabilities 172 M
EFFICIENCY
Earnings Waterfall CONMED Corporation
image
Revenue 1.24 B
Cost Of Revenue 598 M
Gross Profit 643 M
Operating Expenses 564 M
Operating Income 131 M
Other Expenses 66.3 M
Net Income 64.5 M
RATIOS
51.82% GROSS MARGIN
51.82%
10.54% OPERATING MARGIN
10.54%
5.19% NET MARGIN
5.19%
7.73% ROE
7.73%
2.80% ROA
2.80%
5.78% ROIC
5.78%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis CONMED Corporation
image
Net Income 64.5 M
Depreciation & Amortization 51.4 M
Capital Expenditures -19 M
Stock-Based Compensation 24.3 M
Change in Working Capital -39.6 M
Others 2.68 M
Free Cash Flow 106 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets CONMED Corporation
image
Wall Street analysts predict an average 1-year price target for CNMD of $99.7 , with forecasts ranging from a low of $95 to a high of $107 .
CNMD Lowest Price Target Wall Street Target
95 USD 31.51%
CNMD Average Price Target Wall Street Target
99.7 USD 37.97%
CNMD Highest Price Target Wall Street Target
107 USD 48.12%
4. DIVIDEND ANALYSIS
0.28% DIVIDEND YIELD
0.2 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership CONMED Corporation
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
287 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
253 K USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
544 K USD 4
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
5 months ago
Jun 14, 2024
Sell 287 K USD
Peters Stanley W III
President AS and AET
- 4000
71.82 USD
6 months ago
May 13, 2024
Bought 97.3 K USD
BRONSON DAVID M
Director
+ 1350
72.09 USD
6 months ago
May 08, 2024
Bought 99.9 K USD
Schwarzentraub Barbara J
Director
+ 1442
69.26 USD
6 months ago
May 06, 2024
Bought 142 K USD
Aronson Martha Goldberg
Director
+ 2000
70.98 USD
6 months ago
Apr 30, 2024
Bought 205 K USD
Beyer Pat
Chief Operating Officer
+ 3000
68.3 USD
11 months ago
Dec 04, 2023
Sell 253 K USD
Peters Stanley W III
President AS and AET
- 2300
109.9276 USD
1 year ago
Nov 07, 2023
Sell 123 K USD
Peters Stanley W III
President AS and AET
- 1200
102.395 USD
1 year ago
Sep 13, 2023
Sell 215 K USD
Peters Stanley W III
President AS and AET
- 2000
107.3146 USD
1 year ago
Aug 16, 2023
Sell 152 K USD
Garner Todd W
Executive Vice President & CFO
- 1355
111.9998 USD
1 year ago
Jun 15, 2023
Sell 136 K USD
Hartman Curt R
President, CEO and Chair
- 1000
136 USD
1 year ago
Jun 08, 2023
Sell 656 K USD
Peters Stanley W III
VP GM Advanced Surgery
- 5000
131.1352 USD
1 year ago
Jun 08, 2023
Sell 224 K USD
Ferrell John D.
Executive Vice President - HR
- 1700
131.81 USD
1 year ago
Jun 07, 2023
Sell 105 K USD
CONCANNON BRIAN
Director
- 812
129.01 USD
1 year ago
May 22, 2023
Sell 181 K USD
Peters Stanley W III
VP GM Advanced Surgery
- 1500
120.895 USD
1 year ago
May 18, 2023
Sell 179 K USD
Peters Stanley W III
VP GM Advanced Surgery
- 1500
119.2407 USD
1 year ago
May 01, 2023
Sell 259 K USD
CONCANNON BRIAN
Director
- 2072
125 USD
1 year ago
Apr 28, 2023
Sell 313 K USD
SHAGORY PETER K
EVP, STRAT & CORP DEVT
- 2442
128 USD
1 year ago
Apr 28, 2023
Sell 167 K USD
Pelletier Johonna Marie
Treasurer and VP, Tax
- 1317
127.06 USD
1 year ago
Apr 28, 2023
Sell 253 K USD
Pelletier Johonna Marie
Treasurer and VP, Tax
- 2000
126.45 USD
1 year ago
Apr 28, 2023
Sell 683 K USD
Pelletier Johonna Marie
Treasurer and VP, Tax
- 5400
126.43 USD
1 year ago
Apr 28, 2023
Sell 681 K USD
Pelletier Johonna Marie
Treasurer and VP, Tax
- 5400
126.18 USD
1 year ago
Apr 28, 2023
Sell 644 K USD
Pelletier Johonna Marie
Treasurer and VP, Tax
- 5100
126.37 USD
1 year ago
Apr 28, 2023
Sell 606 K USD
Pelletier Johonna Marie
Treasurer and VP, Tax
- 4800
126.33 USD
1 year ago
Apr 28, 2023
Sell 691 K USD
Jonas Daniel S
Special Counsel & Corp Secy
- 5500
125.57 USD
1 year ago
Apr 28, 2023
Sell 545 K USD
Jonas Daniel S
Special Counsel & Corp Secy
- 4300
126.72 USD
1 year ago
Apr 28, 2023
Sell 25.5 K USD
Jonas Daniel S
Special Counsel & Corp Secy
- 200
127.56 USD
1 year ago
Apr 28, 2023
Sell 357 K USD
Berge Terence M
VP-Corporate Controller
- 2800
127.44 USD
1 year ago
Apr 28, 2023
Sell 685 K USD
Berge Terence M
VP-Corporate Controller
- 5400
126.78 USD
1 year ago
Apr 28, 2023
Sell 683 K USD
Berge Terence M
VP-Corporate Controller
- 5400
126.42 USD
1 year ago
Apr 28, 2023
Sell 646 K USD
Berge Terence M
VP-Corporate Controller
- 5100
126.65 USD
1 year ago
Mar 14, 2023
Sell 464 K USD
Hartman Curt R
President, CEO and Chair
- 5000
92.8057 USD
1 year ago
Mar 13, 2023
Sell 115 K USD
Garner Todd W
Executive Vice President & CFO
- 1300
88.7819 USD
1 year ago
Mar 13, 2023
Sell 618 K USD
Garner Todd W
Executive Vice President & CFO
- 6849
90.3044 USD
1 year ago
Mar 13, 2023
Sell 1.63 M USD
Garner Todd W
Executive Vice President & CFO
- 17926
91.1009 USD
1 year ago
Mar 13, 2023
Sell 352 K USD
Garner Todd W
Executive Vice President & CFO
- 3825
91.9452 USD
1 year ago
Mar 13, 2023
Sell 9.26 K USD
Garner Todd W
Executive Vice President & CFO
- 100
92.63 USD
1 year ago
Mar 02, 2023
Sell 520 K USD
Jonas Daniel S
Special Counsel & Corp Secy
- 5400
96.245 USD
1 year ago
Mar 02, 2023
Sell 480 K USD
Jonas Daniel S
Special Counsel & Corp Secy
- 5000
96.0762 USD
1 year ago
Dec 09, 2022
Sell 402 K USD
Garner Todd W
Executive Vice President & CFO
- 4500
89.31 USD
2 years ago
Aug 12, 2022
Sell 757 K USD
Peters Stanley W III
VP GM Advanced Surgery
- 7500
100.9 USD
2 years ago
Jun 13, 2022
Sell 266 K USD
Garner Todd W
Executive Vice President & CFO
- 2662
99.79 USD
2 years ago
May 13, 2022
Sell 178 K USD
Lande Jerome J.
director:
- 1521
117 USD
2 years ago
Mar 15, 2022
Sell 346 K USD
Hartman Curt R
President, CEO and Chair
- 2500
138.429 USD
2 years ago
Mar 04, 2022
Sell 514 K USD
Jonas Daniel S
EVP Legal Affairs,Gen. Counsel
- 3610
142.4214 USD
2 years ago
Mar 04, 2022
Sell 1.59 M USD
Jonas Daniel S
EVP Legal Affairs,Gen. Counsel
- 11157
142.5 USD
2 years ago
Mar 04, 2022
Sell 199 K USD
Jonas Daniel S
EVP Legal Affairs,Gen. Counsel
- 1390
143.296 USD
2 years ago
Mar 03, 2022
Sell 120 K USD
KENNEDY JOHN JED
Group Executive Vice President
- 832
144.3304 USD
2 years ago
Mar 03, 2022
Sell 258 K USD
KENNEDY JOHN JED
Group Executive Vice President
- 1790
144.3174 USD
2 years ago
Mar 03, 2022
Sell 735 K USD
KENNEDY JOHN JED
Group Executive Vice President
- 5092
144.2521 USD
2 years ago
Mar 01, 2022
Sell 16 K USD
KENNEDY JOHN JED
Group Executive Vice President
- 110
145.5 USD
2 years ago
Feb 25, 2022
Sell 499 K USD
Jonas Daniel S
EVP Legal Affairs,Gen. Counsel
- 3343
149.4112 USD
2 years ago
Feb 25, 2022
Sell 561 K USD
Jonas Daniel S
EVP Legal Affairs,Gen. Counsel
- 3755
149.4557 USD
2 years ago
Feb 25, 2022
Sell 75 K USD
Jonas Daniel S
EVP Legal Affairs,Gen. Counsel
- 500
150.0307 USD
2 years ago
Feb 25, 2022
Sell 187 K USD
Jonas Daniel S
EVP Legal Affairs,Gen. Counsel
- 1245
150 USD
2 years ago
Feb 25, 2022
Sell 952 K USD
Peters Stanley W III
VP GM Advanced Surgery
- 6418
148.357 USD
2 years ago
Feb 25, 2022
Sell 236 K USD
Peters Stanley W III
VP GM Advanced Surgery
- 1582
149.356 USD
2 years ago
Feb 25, 2022
Sell 400 K USD
Peters Stanley W III
VP GM Advanced Surgery
- 2700
148 USD
2 years ago
Feb 02, 2022
Sell 274 K USD
CONCANNON BRIAN
Director
- 2027
135.09 USD
2 years ago
Feb 02, 2022
Sell 575 K USD
CONCANNON BRIAN
Director
- 4200
136.96 USD
2 years ago
Feb 02, 2022
Sell 249 K USD
CONCANNON BRIAN
Director
- 1843
135.06 USD
2 years ago
Feb 02, 2022
Sell 292 K USD
CONCANNON BRIAN
Director
- 2165
135.08 USD
2 years ago
Feb 02, 2022
Sell 27.6 K USD
CONCANNON BRIAN
Director
- 200
137.91 USD
3 years ago
Nov 05, 2021
Sell 454 K USD
TRYNISKI MARK E
Director
- 2899
156.439 USD
3 years ago
Nov 05, 2021
Sell 454 K USD
TRYNISKI MARK E
Director
- 2899
156.439 USD
3 years ago
Nov 05, 2021
Sell 373 K USD
TRYNISKI MARK E
Director
- 2386
156.436 USD
3 years ago
Nov 05, 2021
Sell 373 K USD
TRYNISKI MARK E
Director
- 2386
156.436 USD
3 years ago
Nov 05, 2021
Sell 273 K USD
TRYNISKI MARK E
Director
- 1743
156.483 USD
3 years ago
Nov 05, 2021
Sell 750 K USD
TRYNISKI MARK E
Director
- 4792
156.508 USD
3 years ago
Nov 05, 2021
Sell 750 K USD
TRYNISKI MARK E
Director
- 4792
156.508 USD
3 years ago
Nov 05, 2021
Sell 273 K USD
TRYNISKI MARK E
Director
- 1743
156.483 USD
3 years ago
Nov 05, 2021
Sell 15.7 K USD
TRYNISKI MARK E
Director
- 100
157.05 USD
3 years ago
Nov 05, 2021
Sell 15.7 K USD
TRYNISKI MARK E
Director
- 100
157.05 USD
3 years ago
Nov 05, 2021
Sell 78.5 K USD
TRYNISKI MARK E
Director
- 500
157.061 USD
3 years ago
Nov 05, 2021
Sell 78.5 K USD
TRYNISKI MARK E
Director
- 500
156.949 USD
3 years ago
Nov 05, 2021
Sell 78.5 K USD
TRYNISKI MARK E
Director
- 500
156.949 USD
3 years ago
Nov 05, 2021
Sell 15.7 K USD
TRYNISKI MARK E
Director
- 100
157.11 USD
3 years ago
Nov 05, 2021
Sell 15.7 K USD
TRYNISKI MARK E
Director
- 100
157.11 USD
3 years ago
Nov 05, 2021
Sell 78.5 K USD
TRYNISKI MARK E
Director
- 500
157.061 USD
3 years ago
Nov 04, 2021
Sell 192 K USD
Pelletier Johonna Marie
Treasurer and VP, Tax
- 1247
154.138 USD
3 years ago
Nov 04, 2021
Sell 835 K USD
Pelletier Johonna Marie
Treasurer and VP, Tax
- 5400
154.56 USD
3 years ago
Nov 04, 2021
Sell 394 K USD
Pelletier Johonna Marie
Treasurer and VP, Tax
- 2550
154.615 USD
3 years ago
Nov 04, 2021
Sell 2.16 M USD
Peters Stanley W III
VP GM Advanced Surgery
- 14000
154.061 USD
3 years ago
Nov 03, 2021
Sell 59 K USD
Beyer Pat
President Int'l & Global Ortho
- 400
147.505 USD
3 years ago
Nov 03, 2021
Sell 1.57 M USD
Beyer Pat
President Int'l & Global Ortho
- 10550
148.472 USD
3 years ago
Nov 03, 2021
Sell 969 K USD
Beyer Pat
President Int'l & Global Ortho
- 6497
149.199 USD
3 years ago
Nov 02, 2021
Sell 268 K USD
KENNEDY JOHN JED
Group Executive Vice President
- 1822
147.057 USD
3 years ago
Nov 02, 2021
Sell 137 K USD
KENNEDY JOHN JED
Group Executive Vice President
- 928
147.512 USD
3 years ago
Nov 02, 2021
Sell 484 K USD
KENNEDY JOHN JED
Group Executive Vice President
- 3278
147.57 USD
3 years ago
Nov 02, 2021
Sell 126 K USD
KENNEDY JOHN JED
Group Executive Vice President
- 862
146.668 USD
3 years ago
Nov 02, 2021
Sell 129 K USD
KENNEDY JOHN JED
Group Executive Vice President
- 872
148.313 USD
3 years ago
Nov 02, 2021
Sell 253 K USD
KENNEDY JOHN JED
Group Executive Vice President
- 1700
148.596 USD
3 years ago
Oct 29, 2021
Sell 403 K USD
Beyer Pat
President Int'l & Global Ortho
- 2789
144.497 USD
3 years ago
Oct 29, 2021
Sell 2.46 M USD
Beyer Pat
President Int'l & Global Ortho
- 16904
145.307 USD
3 years ago
Oct 29, 2021
Sell 817 K USD
Beyer Pat
President Int'l & Global Ortho
- 5589
146.135 USD
3 years ago
Oct 04, 2021
Sell 403 K USD
Garner Todd W
Executive Vice President & CFO
- 3117
129.378 USD
3 years ago
Oct 04, 2021
Sell 401 K USD
Garner Todd W
Executive Vice President & CFO
- 3083
130.048 USD
3 years ago
Oct 04, 2021
Sell 105 K USD
Garner Todd W
Executive Vice President & CFO
- 800
131.492 USD
3 years ago
Oct 04, 2021
Sell 119 K USD
Garner Todd W
Executive Vice President & CFO
- 900
132.651 USD
3 years ago
Oct 04, 2021
Sell 7.5 K USD
Garner Todd W
Executive Vice President & CFO
- 58
129.327 USD
3 years ago
Oct 04, 2021
Sell 10.5 K USD
Garner Todd W
Executive Vice President & CFO
- 81
130.129 USD
3 years ago
Oct 04, 2021
Sell 2.63 K USD
Garner Todd W
Executive Vice President & CFO
- 20
131.625 USD
3 years ago
Oct 04, 2021
Sell 66.7 K USD
Garner Todd W
Executive Vice President & CFO
- 500
133.446 USD
3 years ago
Oct 04, 2021
Sell 4.26 K USD
Garner Todd W
Executive Vice President & CFO
- 32
132.985 USD
3 years ago
Sep 15, 2021
Sell 318 K USD
Hartman Curt R
President, CEO and Chair
- 2500
127.387 USD
3 years ago
Sep 15, 2021
Sell 427 K USD
Jonas Daniel S
EVP Legal Affairs,Gen. Counsel
- 3357
127.2571 USD
3 years ago
Sep 15, 2021
Sell 141 K USD
Garner Todd W
Executive Vice President & CFO
- 1131
124.92 USD
3 years ago
Aug 30, 2021
Sell 490 K USD
KENNEDY JOHN JED
Group Executive Vice President
- 3640
134.7501 USD
3 years ago
Aug 30, 2021
Sell 27 K USD
KENNEDY JOHN JED
Group Executive Vice President
- 200
134.75 USD
3 years ago
Aug 27, 2021
Sell 666 K USD
KENNEDY JOHN JED
Group Executive Vice President
- 4940
134.7768 USD
3 years ago
Aug 27, 2021
Sell 67.1 K USD
KENNEDY JOHN JED
Group Executive Vice President
- 498
134.75 USD
3 years ago
Aug 13, 2021
Sell 166 K USD
Garner Todd W
Executive Vice President & CFO
- 1350
122.76 USD
3 years ago
Jun 15, 2021
Sell 132 K USD
Garner Todd W
Executive Vice President & CFO
- 960
137.04 USD
3 years ago
Jun 15, 2021
Sell 132 K USD
Garner Todd W
Executive Vice President & CFO
- 960
137.04 USD
3 years ago
Jun 11, 2021
Sell 252 K USD
Schwarzentraub Barbara J
Director
- 1843
136.903 USD
3 years ago
Jun 03, 2021
Sell 5.59 M USD
Hartman Curt R
President, CEO and Chair
- 42347
132.087 USD
3 years ago
May 14, 2021
Sell 1.15 M USD
Hartman Curt R
President, CEO and Chair
- 8030
142.85 USD
3 years ago
May 14, 2021
Sell 714 K USD
Hartman Curt R
President, CEO and Chair
- 5000
142.89 USD
3 years ago
May 14, 2021
Sell 177 K USD
Garner Todd W
Executive Vice President & CFO
- 1257
141.19 USD
3 years ago
May 05, 2021
Sell 569 K USD
Cohen Heather L
EVP CORP HR
- 4017
141.673 USD
3 years ago
May 05, 2021
Sell 64.5 K USD
Cohen Heather L
EVP CORP HR
- 450
143.327 USD
3 years ago
May 05, 2021
Sell 21.6 K USD
Cohen Heather L
EVP CORP HR
- 150
144.15 USD
3 years ago
Apr 30, 2021
Sell 85.5 K USD
Jonas Daniel S
EVP Legal Affairs,Gen. Counsel
- 600
142.581 USD
3 years ago
Apr 30, 2021
Sell 1.41 M USD
Jonas Daniel S
EVP Legal Affairs,Gen. Counsel
- 10000
141.075 USD
3 years ago
Apr 30, 2021
Sell 14.3 K USD
Jonas Daniel S
EVP Legal Affairs,Gen. Counsel
- 100
143.3 USD
3 years ago
Apr 30, 2021
Sell 710 K USD
Jonas Daniel S
EVP Legal Affairs,Gen. Counsel
- 5000
142 USD
3 years ago
May 03, 2021
Sell 608 K USD
Jonas Daniel S
EVP Legal Affairs,Gen. Counsel
- 4176
145.5906 USD
7. News
Conmed (CNMD) is a Top-Ranked Momentum Stock: Should You Buy? Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. zacks.com - 1 day ago
Why Conmed (CNMD) is a Top Value Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 5 days ago
Here's Why Conmed (CNMD) is a Strong Growth Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 1 week ago
CONMED Beats on Q3 Earnings, Misses on Sales, Lowers '24 Sales View CNMD's Q3 earnings beat estimates on the back of higher revenues and lower costs and expenses. zacks.com - 2 weeks ago
CONMED Corporation (CNMD) Q3 2024 Earnings Call Transcript CONMED Corporation (NYSE:CNMD ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Curt Hartman – Chairman, President and Chief Executive Officer Pat Beyer – Chief Operating Officer Todd Garner – Executive Vice President and Chief Financial Officer Conference Call Participants Kristen Stewart – C.L. King Lily Delaney – JPMorgan Dino Weinstock – Wells Fargo Operator Good day and thank you for standing by. seekingalpha.com - 2 weeks ago
Conmed (CNMD) Reports Q3 Earnings: What Key Metrics Have to Say The headline numbers for Conmed (CNMD) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com - 2 weeks ago
Conmed (CNMD) Surpasses Q3 Earnings Estimates Conmed (CNMD) came out with quarterly earnings of $1.05 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $0.90 per share a year ago. zacks.com - 2 weeks ago
CONMED Corporation Announces Third Quarter 2024 Financial Results LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Sales of $316.7 million increased 4.0% year-over-year as reported and 4.3% in constant currency. Diluted net earnings per share (GAAP) were $1.57 compared to diluted net earnings per share (GAAP) of $0.50 in the third quarter of 2023. Adjusted diluted net earnings per share(1) were $1.05, an increase of 16.7% compared to th. businesswire.com - 2 weeks ago
CONMED Corporation Announces Leadership Succession LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman will retire as President and Chief Executive Officer (CEO) of the Company, effective January 1, 2025. Patrick Beyer, current Chief Operating Officer (COO) of CONMED, will succeed Mr. Hartman as President and CEO and will also be appointed as a member of the Company's board, effective the same date. As part of the transition, Lead Independent Director Martha Goldberg Aronson will assume the positio. businesswire.com - 2 weeks ago
Conmed (CNMD) Earnings Expected to Grow: Should You Buy? Conmed (CNMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 3 weeks ago
Here's Why Conmed (CNMD) is a Strong Growth Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. zacks.com - 3 weeks ago
Will Conmed (CNMD) Beat Estimates Again in Its Next Earnings Report? Conmed (CNMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. zacks.com - 1 month ago
8. Profile Summary

CONMED Corporation CNMD

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 2.23 B
Dividend Yield 0.28%
Description CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Contact 11311 Concept Boulevard, Largo, FL, 33773-4908 https://www.conmed.com
IPO Date July 23, 1987
Employees 4000
Officers Ms. Kimberly A. Lockwood Interim Corporate Controller Mr. Curt R. Hartman President, Chief Executive Officer & Director Mr. Patrick J. Beyer Chief Operating Officer Mr. Richard Glaze Chief Information Officer Mr. David R. Murray President of ConMed Electrosurgery